person · Reporting owner

Molly Montgomery

Disclosed activity across 6 companies

Tapewire entity: 88609
SEC CIK: 0001465272

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Benson Hill, Inc.BHIL · Entity 87189	Director	July 18, 2024	August 01, 2024
QualTek Services Inc.ROCRU · Entity 115163	Director	March 05, 2021	March 08, 2021
Reservoir Media, Inc.ROCCU · Entity 5296	Director	December 15, 2020	December 17, 2020
Roth CH Acquisition I CoROCHU · Entity 148912	Director	May 07, 2020	May 11, 2020

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Benson Hill, Inc.

Report date July 18, 2024 · Filed August 01, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, $0.0001 par value per shareSEC Table I · non-derivative	Direct	6,481	Reported balance After 2024-07-18 transaction · row 1 1 source row Row 1 · 2024-07-18 · Exercise / conversion · Acquired 4,352 · Balance 6,481 F1: Represents vesting of restricted stock units granted on August 11, 2023 under the Issuer's 2021 Omnibus Incentive Plan. F2: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2024-07-18 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2024-07-18 · Exercise / conversion · Disposed 4,352 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1: Represents vesting of restricted stock units granted on August 11, 2023 under the Issuer's 2021 Omnibus Incentive Plan.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	10,675	Reported balance After 2024-07-18 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2024-07-18 · Grant · Acquired 10,675 · Balance 10,675 F2: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3: Granted on July 18, 2024 (the "Grant Date") under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units vest in full on the earlier of the first anniversary of the Grant Date or the Issuer's 2025 Annual Meeting of Stockholders.

Filing footnotes · ownership attribution and instrument terms

F1: Represents vesting of restricted stock units granted on August 11, 2023 under the Issuer's 2021 Omnibus Incentive Plan.

F2: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3: Granted on July 18, 2024 (the "Grant Date") under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units vest in full on the earlier of the first anniversary of the Grant Date or the Issuer's 2025 Annual Meeting of Stockholders.

QualTek Services Inc.

Report date March 05, 2021 · Filed March 08, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	40,233	Reported balance After 2021-03-05 transaction · row 1 1 source row Row 1 · 2021-03-05 · Purchase · Acquired 5,000 · Balance 40,233 F1: The reporting person acquired units, consisting of shares and warrants.
Warrants to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $11.50	Direct	1,250	Reported balance After 2021-03-05 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2021-03-05 · Purchase · Acquired 1,250 · Balance 1,250 F1: The reporting person acquired units, consisting of shares and warrants. F2: The warrants become exercisable 30 days after the consummation of the registrant's initial business combination. F3: The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC.

Filing footnotes · ownership attribution and instrument terms

F1: The reporting person acquired units, consisting of shares and warrants.

F2: The warrants become exercisable 30 days after the consummation of the registrant's initial business combination.

F3: The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC.

Reservoir Media, Inc.

Report date December 15, 2020 · Filed December 17, 2020

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	88,189	Reported balance After 2020-12-15 transaction · row 1 1 source row Row 1 · 2020-12-15 · Purchase · Acquired 7,699 · Balance 88,189 F1: The reporting person acquired units, consisting of shares and warrants.
Warrants to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $11.50	Direct	3,849	Reported balance After 2020-12-15 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2020-12-15 · Purchase · Acquired 3,849 · Balance 3,849 F1: The reporting person acquired units, consisting of shares and warrants. F2: The warrants become exercisable 30 days after the consummation of the registrant's initial business combination. F3: The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC.

Filing footnotes · ownership attribution and instrument terms

F1: The reporting person acquired units, consisting of shares and warrants.

F2: The warrants become exercisable 30 days after the consummation of the registrant's initial business combination.

Roth CH Acquisition I Co

Report date May 07, 2020 · Filed May 11, 2020

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	85,658	Reported balance After 2020-05-07 transaction · row 1 1 source row Row 1 · 2020-05-07 · Purchase · Acquired 10,000 · Balance 85,658 F1: The reporting person acquired units, consisting of shares and warrants.
Warrants to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $11.50	Direct	7,500	Reported balance After 2020-05-07 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2020-05-07 · Purchase · Acquired 7,500 · Balance 7,500 F1: The reporting person acquired units, consisting of shares and warrants. F2: The warrants become exercisable on the later of (i) the completion of the registrant's initial business combination and (ii) 12 months from the closing of the registrant's initial public offering. F3: The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC.

Filing footnotes · ownership attribution and instrument terms

F1: The reporting person acquired units, consisting of shares and warrants.

F2: The warrants become exercisable on the later of (i) the completion of the registrant's initial business combination and (ii) 12 months from the closing of the registrant's initial public offering.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

LIFECORE BIOMEDICAL, INC. \DE\

Report date May 23, 2019 · Filed August 06, 2019 · Amendment

Section 16 reporting ended · disclosed 2019-08-06. Current position is not established by this disclosure.

Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	155,015	Last balance in matching sequence After 2019-05-23 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2019-05-23 · Exercise / conversion · Acquired 71,575 · Balance 179,765 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2: Original filing on 5/23/19 and subsequent amendment filing on 5/29/19 inadvertently reported incorrect total number of shares. Row 2 · 2019-05-23 · Tax withholding · Disposed 24,750 · Balance 155,015 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2: Original filing on 5/23/19 and subsequent amendment filing on 5/29/19 inadvertently reported incorrect total number of shares.
Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2019-05-23	Direct	71,575	Reported balance After 2019-05-23 transaction · row 3 Amendment: may correct only part of an earlier disclosure. 1 source row Row 3 · 2019-05-23 · Exercise / conversion · Disposed 71,575 · Balance 71,575 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F3: Restricted Stock Unit awards granted on July 21,2016, October 19,2017 and July 22, 2018 have accelerated due to resignation on May 23, 2019.

Filing footnotes · ownership attribution and instrument terms

F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2: Original filing on 5/23/19 and subsequent amendment filing on 5/29/19 inadvertently reported incorrect total number of shares.

F3: Restricted Stock Unit awards granted on July 21,2016, October 19,2017 and July 22, 2018 have accelerated due to resignation on May 23, 2019.

TIGO ENERGY, INC.

Report date May 23, 2023 · Filed May 25, 2023

Section 16 reporting ended · disclosed 2023-05-25. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	12,549	Reported balance After 2023-05-23 transaction · row 1 1 source row Row 1 · 2023-05-23 · Sale · Disposed 20,485 · Balance 12,549 F1: The reporting person disposed of (i) 16,287 shares of common stock and (ii) 4,198 units, each unit consisting of one share of common stock and one-half of one warrant, for total consideration of $22,770.75.
Warrants to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $11.50	Direct	185	Reported balance After 2023-05-23 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2023-05-23 · Sale · Disposed 2,099 · Balance 185 F1: The reporting person disposed of (i) 16,287 shares of common stock and (ii) 4,198 units, each unit consisting of one share of common stock and one-half of one warrant, for total consideration of $22,770.75. F2: The warrants become exercisable 30 days after the consummation of the registrant's initial business combination. F3: The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC.

Filing footnotes · ownership attribution and instrument terms

F1: The reporting person disposed of (i) 16,287 shares of common stock and (ii) 4,198 units, each unit consisting of one share of common stock and one-half of one warrant, for total consideration of $22,770.75.

F2: The warrants become exercisable 30 days after the consummation of the registrant's initial business combination.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
July 18, 2024 Filed Aug 1, 2024 21:10 UTC	Benson Hill, Inc. BHIL · Entity 87189	GrantRestricted Stock Units · Derivative	10,675	$0.00	$0.00	Disclosure SEC source: 0001830210-24-000105 · wk-form4_1722561010.xml · derivative · entry 3 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,675 Underlying: Common Stock, $0.0001 par value per share · 10,675 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: Granted on July 18, 2024 (the "Grant Date") under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units vest in full on the earlier of the first anniversary of the Grant Date or the Issuer's 2025 Annual Meeting of Stockholders. F3 · derivative.expiration_date: Granted on July 18, 2024 (the "Grant Date") under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units vest in full on the earlier of the first anniversary of the Grant Date or the Issuer's 2025 Annual Meeting of Stockholders. Read SEC document
July 18, 2024 Filed Aug 1, 2024 21:10 UTC	Benson Hill, Inc. BHIL · Entity 87189	Exercise / conversionRestricted Stock Units · Derivative	4,352	$0.00	$0.00	Disclosure SEC source: 0001830210-24-000105 · wk-form4_1722561010.xml · derivative · entry 2 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.0001 par value per share · 4,352 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1 · derivative.exercise_date: Represents vesting of restricted stock units granted on August 11, 2023 under the Issuer's 2021 Omnibus Incentive Plan. F1 · derivative.expiration_date: Represents vesting of restricted stock units granted on August 11, 2023 under the Issuer's 2021 Omnibus Incentive Plan. Read SEC document
July 18, 2024 Filed Aug 1, 2024 21:10 UTC	Benson Hill, Inc. BHIL · Entity 87189	Exercise / conversionCommon Stock, $0.0001 par value per share	4,352	Not disclosed	Not disclosed	Disclosure SEC source: 0001830210-24-000105 · wk-form4_1722561010.xml · nonDerivative · entry 1 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of restricted stock units granted on August 11, 2023 under the Issuer's 2021 Omnibus Incentive Plan. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document
September 29, 2023 Filed Oct 3, 2023 16:27 UTC	Benson Hill, Inc. BHIL · Entity 87189	Exercise / conversionRestricted Stock Units · Derivative	22,327	$0.00	$0.00	Disclosure SEC source: 0001830210-23-000174 · wk-form4_1696364812.xml · derivative · entry 3 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.0001 par value per share · 22,327 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1 · derivative.exercise_date: Represents vesting of the second of two tranches of restricted stock units granted on December 9, 2021 under the Issuer's 2021 Omnibus Incentive Plan. F1 · derivative.expiration_date: Represents vesting of the second of two tranches of restricted stock units granted on December 9, 2021 under the Issuer's 2021 Omnibus Incentive Plan. Read SEC document
September 29, 2023 Filed Oct 3, 2023 16:27 UTC	Benson Hill, Inc. BHIL · Entity 87189	SaleCommon Stock	8,484	$0.33	$2,813.29	Disclosure SEC source: 0001830210-23-000174 · wk-form4_1696364812.xml · nonDerivative · entry 2 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,529 F3 · kind: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F4 · price: This transaction was executed in multiple trades with sales prices ranging from $0.3250 to $0.3370. The price reported above reflects the average weighted sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
September 29, 2023 Filed Oct 3, 2023 16:27 UTC	Benson Hill, Inc. BHIL · Entity 87189	Exercise / conversionCommon Stock	22,327	Not disclosed	Not disclosed	Disclosure SEC source: 0001830210-23-000174 · wk-form4_1696364812.xml · nonDerivative · entry 1 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of the second of two tranches of restricted stock units granted on December 9, 2021 under the Issuer's 2021 Omnibus Incentive Plan. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document
August 11, 2023 Filed Aug 15, 2023 17:21 UTC	Benson Hill, Inc. BHIL · Entity 87189	GrantRestricted Stock Units · Derivative	152,334	$0.00	$0.00	Disclosure SEC source: 0001830210-23-000160 · wk-form4_1692134477.xml · derivative · entry 1 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,334 Underlying: Common Stock, $0.0001 par value per share · 152,334 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: Granted on August 11, 2023 (the "Grant Date") under the Issuer's 2021 Omnibus Incentive Plan. the restricted stock units vest in full on the earlier of the first anniversary of the Grant Date or the Issuer's 2024 Annual Meeting of Stockholders. F2 · derivative.expiration_date: Granted on August 11, 2023 (the "Grant Date") under the Issuer's 2021 Omnibus Incentive Plan. the restricted stock units vest in full on the earlier of the first anniversary of the Grant Date or the Issuer's 2024 Annual Meeting of Stockholders. Read SEC document
July 03, 2023 Filed Jul 5, 2023 15:03 UTC	Benson Hill, Inc. BHIL · Entity 87189	SaleCommon Stock	23,510	$1.24	$29,175.91	Disclosure SEC source: 0001830210-23-000128 · wk-form4_1688583815.xml · nonDerivative · entry 2 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,686 F3 · price: This transaction was executed in multiple trades with sales prices ranging from $1.21 to $1.33. The price reported above reflects the average weighted sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
July 01, 2023 Filed Jul 5, 2023 15:03 UTC	Benson Hill, Inc. BHIL · Entity 87189	Exercise / conversionRestricted Stock Units · Derivative	61,869	$0.00	$0.00	Disclosure SEC source: 0001830210-23-000128 · wk-form4_1688583815.xml · derivative · entry 3 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.0001 par value per share · 61,869 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1 · derivative.exercise_date: Represents vesting of restricted stock units granted on July 1, 2022 under the Issuer's 2021 Omnibus Incentive Plan. F1 · derivative.expiration_date: Represents vesting of restricted stock units granted on July 1, 2022 under the Issuer's 2021 Omnibus Incentive Plan. Read SEC document
July 01, 2023 Filed Jul 5, 2023 15:03 UTC	Benson Hill, Inc. BHIL · Entity 87189	Exercise / conversionCommon Stock	61,869	Not disclosed	Not disclosed	Disclosure SEC source: 0001830210-23-000128 · wk-form4_1688583815.xml · nonDerivative · entry 1 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of restricted stock units granted on July 1, 2022 under the Issuer's 2021 Omnibus Incentive Plan. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document
May 23, 2023 Filed May 25, 2023 21:46 UTC	TIGO ENERGY, INC. TYGO · Entity 6903	SaleWarrants to purchase common stock · Derivative	2,099	Not disclosed Strike: $11.50	Not disclosed	Disclosure SEC source: 0001104659-23-064793 · tm2316861-11_4seq1.xml · derivative · entry 2 Molly Montgomery · CIK 0001465272 · former director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185 Underlying: Common Stock · 2,099 shares Expires not disclosed F1 · price: The reporting person disposed of (i) 16,287 shares of common stock and (ii) 4,198 units, each unit consisting of one share of common stock and one-half of one warrant, for total consideration of $22,770.75. F2 · derivative.exercise_date: The warrants become exercisable 30 days after the consummation of the registrant's initial business combination. F3 · derivative.expiration_date: The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC. Read SEC document
May 23, 2023 Filed May 25, 2023 21:46 UTC	TIGO ENERGY, INC. TYGO · Entity 6903	SaleCommon Stock	20,485	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-23-064793 · tm2316861-11_4seq1.xml · nonDerivative · entry 1 Molly Montgomery · CIK 0001465272 · former director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,549 F1 · price: The reporting person disposed of (i) 16,287 shares of common stock and (ii) 4,198 units, each unit consisting of one share of common stock and one-half of one warrant, for total consideration of $22,770.75. Read SEC document
September 29, 2022 Filed Oct 3, 2022 16:38 UTC	Benson Hill, Inc. BHIL · Entity 87189	Exercise / conversionRestricted Stock Units · Derivative	22,327	$0.00	$0.00	Disclosure SEC source: 0001830210-22-000172 · wf-form4_166482946501418.xml · derivative · entry 2 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,327 Underlying: Common Stock, $0.0001 par value per share · 22,327 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1 · derivative.exercise_date: Represents vesting of the first of two tranches of restricted stock units granted on December 9, 2021. The final tranche will vest on September 29, 2023. F1 · derivative.expiration_date: Represents vesting of the first of two tranches of restricted stock units granted on December 9, 2021. The final tranche will vest on September 29, 2023. Read SEC document
September 29, 2022 Filed Oct 3, 2022 16:38 UTC	Benson Hill, Inc. BHIL · Entity 87189	Exercise / conversionCommon Stock	22,327	Not disclosed	Not disclosed	Disclosure SEC source: 0001830210-22-000172 · wf-form4_166482946501418.xml · nonDerivative · entry 1 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of the first of two tranches of restricted stock units granted on December 9, 2021. The final tranche will vest on September 29, 2023. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document
July 01, 2022 Filed Jul 6, 2022 09:27 UTC	Benson Hill, Inc. BHIL · Entity 87189	GrantRestricted Stock Units · Derivative	61,869	$0.00	$0.00	Disclosure SEC source: 0001830210-22-000133 · wf-form4_165711401009500.xml · derivative · entry 1 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,869 Underlying: Common Stock, $0.0001 par value per share · 61,869 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: Granted on July 1, 2022 (the "Grant Date") under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units vest in full on the earlier of the first anniversary of the Grant Date or the Issuer's 2023 Annual Meeting of Stockholders. F2 · derivative.expiration_date: Granted on July 1, 2022 (the "Grant Date") under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units vest in full on the earlier of the first anniversary of the Grant Date or the Issuer's 2023 Annual Meeting of Stockholders. Read SEC document
December 09, 2021 Filed Dec 14, 2021 12:00 UTC Amendment	Benson Hill, Inc. BHIL · Entity 87189	GrantRestricted Stock Units · Derivative	44,654	$0.00	$0.00	Disclosure SEC source: 0001830210-21-000023 · wf-form4a_163950120952186.xml · derivative · entry 1 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,654 Underlying: Common Stock, $0.0001 par value per share · 44,654 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The reporting owner filed a Form 4 on December 14, 2021 that erroneously listed the restricted stock units vesting dates as September 21, 2022 and September 21, 2023. The restricted stock units vest in two equal tranches on September 29, 2022 and September 29, 2023, respectively. F2 · derivative.expiration_date: The reporting owner filed a Form 4 on December 14, 2021 that erroneously listed the restricted stock units vesting dates as September 21, 2022 and September 21, 2023. The restricted stock units vest in two equal tranches on September 29, 2022 and September 29, 2023, respectively. Read SEC document
December 09, 2021 Filed Dec 14, 2021 06:00 UTC	Benson Hill, Inc. BHIL · Entity 87189	GrantRestricted Stock Units · Derivative	44,654	$0.00	$0.00	Disclosure SEC source: 0001830210-21-000020 · wf-form4_163947961712789.xml · derivative · entry 1 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,654 Underlying: Common Stock, $0.0001 par value per share · 44,654 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: Granted on December 9, 2021. The restricted stock units vest in two equal tranches on September 21, 2022 and September 21, 2023, respectively. F2 · derivative.expiration_date: Granted on December 9, 2021. The restricted stock units vest in two equal tranches on September 21, 2022 and September 21, 2023, respectively. Read SEC document
August 10, 2021 Filed Aug 11, 2021 21:09 UTC	TIGO ENERGY, INC. ROCGU · Entity 6903	PurchaseWarrants to purchase Common Stock · Derivative	2,284	Not disclosed Strike: $11.50	Not disclosed	Disclosure SEC source: 0001104659-21-103560 · tm2124740-9_4seq1.xml · derivative · entry 2 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,284 Underlying: Common Stock · 2,284 shares Expires not disclosed F1 · price: The reporting person acquired units, each unit consisting of one share of common stock and one-half of one warrant. F2 · derivative.exercise_date: The warrants become exercisable 30 days after the consummation of the registrant's initial business combination. F3 · derivative.expiration_date: The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC. Read SEC document
August 10, 2021 Filed Aug 11, 2021 21:09 UTC	TIGO ENERGY, INC. ROCGU · Entity 6903	PurchaseCommon Stock	4,569	$10.00	$45,690.00	Disclosure SEC source: 0001104659-21-103560 · tm2124740-9_4seq1.xml · nonDerivative · entry 1 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,034 F1 · shares: The reporting person acquired units, each unit consisting of one share of common stock and one-half of one warrant. Read SEC document
March 05, 2021 Filed Mar 8, 2021 16:27 UTC	QualTek Services Inc. ROCRU · Entity 115163	PurchaseWarrants to purchase Common Stock · Derivative	1,250	Not disclosed Strike: $11.50	Not disclosed	Disclosure SEC source: 0001104659-21-033292 · tm218954-8_4seq1.xml · derivative · entry 2 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 1,250 shares Expires not disclosed F1 · price: The reporting person acquired units, consisting of shares and warrants. F2 · derivative.exercise_date: The warrants become exercisable 30 days after the consummation of the registrant's initial business combination. F3 · derivative.expiration_date: The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC. Read SEC document
March 05, 2021 Filed Mar 8, 2021 16:27 UTC	QualTek Services Inc. ROCRU · Entity 115163	PurchaseCommon Stock	5,000	$10.00	$50,000.00	Disclosure SEC source: 0001104659-21-033292 · tm218954-8_4seq1.xml · nonDerivative · entry 1 Molly Montgomery · CIK 0001465272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,233 F1 · shares: The reporting person acquired units, consisting of shares and warrants. Read SEC document
December 15, 2020 Filed Dec 17, 2020 16:17 UTC	Reservoir Media, Inc. ROCCU · Entity 5296	PurchaseWarrants to purchase Common Stock · Derivative	3,849	Not disclosed Strike: $11.50	Not disclosed	Disclosure SEC source: 0001104659-20-136859 · tm2036996-24_form4.xml · derivative · entry 2 Hemmeter Molly · CIK 0001465272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,849 Underlying: Common Stock · 3,849 shares Expires not disclosed F1 · price: The reporting person acquired units, consisting of shares and warrants. F2 · derivative.exercise_date: The warrants become exercisable 30 days after the consummation of the registrant's initial business combination. F3 · derivative.expiration_date: The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC. Read SEC document
December 15, 2020 Filed Dec 17, 2020 16:17 UTC	Reservoir Media, Inc. ROCCU · Entity 5296	PurchaseCommon Stock	7,699	$10.00	$76,990.00	Disclosure SEC source: 0001104659-20-136859 · tm2036996-24_form4.xml · nonDerivative · entry 1 Hemmeter Molly · CIK 0001465272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,189 F1 · shares: The reporting person acquired units, consisting of shares and warrants. Read SEC document
May 07, 2020 Filed May 11, 2020 17:43 UTC	Roth CH Acquisition I Co ROCHU · Entity 148912	PurchaseWarrants to purchase Common Stock · Derivative	7,500	Not disclosed Strike: $11.50	Not disclosed	Disclosure SEC source: 0001104659-20-059697 · tm2019305-5_form4.xml · derivative · entry 2 Hemmeter Molly · CIK 0001465272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires not disclosed F1 · price: The reporting person acquired units, consisting of shares and warrants. F2 · derivative.exercise_date: The warrants become exercisable on the later of (i) the completion of the registrant's initial business combination and (ii) 12 months from the closing of the registrant's initial public offering. F3 · derivative.expiration_date: The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC. Read SEC document
May 07, 2020 Filed May 11, 2020 17:43 UTC	Roth CH Acquisition I Co ROCHU · Entity 148912	PurchaseCommon Stock	10,000	$10.00	$100,000.00	Disclosure SEC source: 0001104659-20-059697 · tm2019305-5_form4.xml · nonDerivative · entry 1 Hemmeter Molly · CIK 0001465272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,658 F1 · shares: The reporting person acquired units, consisting of shares and warrants. Read SEC document
June 06, 2019 Filed Jun 10, 2019 20:52 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Exercise / conversionRestricted Stock Unit · Derivative	7,592	$9.55	$72,503.60	Disclosure SEC source: 0001628280-19-007861 · wf-form4_156019994428605.xml · derivative · entry 3 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,592 Underlying: Common Stock · 7,592 shares Expires 2019-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.exercise_date: The restricted stock units were granted on June 6, 2019. F3 · derivative.expiration_date: The restricted stock units vested on June 6, 2019. Read SEC document
June 06, 2019 Filed Jun 10, 2019 20:52 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Tax withholdingCommon Stock	3,764	$9.55	$35,946.20	Disclosure SEC source: 0001628280-19-007861 · wf-form4_156019994428605.xml · nonDerivative · entry 2 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,053 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document
June 06, 2019 Filed Jun 10, 2019 20:52 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Exercise / conversionCommon Stock	7,592	$9.55	$72,503.60	Disclosure SEC source: 0001628280-19-007861 · wf-form4_156019994428605.xml · nonDerivative · entry 1 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document
May 23, 2019 Filed May 29, 2019 01:11 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Exercise / conversionRestricted Stock Unit · Derivative	71,574	$9.35	$669,216.90	Disclosure SEC source: 0001628280-19-007275 · wf-form4_155909230175190.xml · derivative · entry 3 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,574 Underlying: Common Stock · 71,574 shares Expires 2019-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.exercise_date: Restricted Stock Unit awards granted on July 21,2016, October 19,2017 and July 22, 2018 have accelerated due to resignation on May 23, 2019. Read SEC document
May 23, 2019 Filed May 29, 2019 01:11 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Tax withholdingCommon Stock	24,815	$9.35	$232,020.25	Disclosure SEC source: 0001628280-19-007275 · wf-form4_155909230175190.xml · nonDerivative · entry 2 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,159 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document
May 23, 2019 Filed May 29, 2019 01:11 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Exercise / conversionCommon Stock	71,574	$9.35	$669,216.90	Disclosure SEC source: 0001628280-19-007275 · wf-form4_155909230175190.xml · nonDerivative · entry 1 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document
May 23, 2019 Filed May 29, 2019 21:05 UTC Amendment	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Exercise / conversionRestricted Stock Unit · Derivative	71,575	$9.35	$669,226.25	Disclosure SEC source: 0001628280-19-007318 · wf-form4a_155916393434108.xml · derivative · entry 3 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,575 Underlying: Common Stock · 71,575 shares Expires 2019-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.exercise_date: Restricted Stock Unit awards granted on July 21,2016, October 19,2017 and July 22, 2018 have accelerated due to resignation on May 23, 2019. Read SEC document
May 23, 2019 Filed May 29, 2019 21:05 UTC Amendment	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Tax withholdingCommon Stock	24,750	$9.35	$231,412.50	Disclosure SEC source: 0001628280-19-007318 · wf-form4a_155916393434108.xml · nonDerivative · entry 2 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,225 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document
May 23, 2019 Filed May 29, 2019 21:05 UTC Amendment	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Exercise / conversionCommon Stock	71,575	$9.35	$669,226.25	Disclosure SEC source: 0001628280-19-007318 · wf-form4a_155916393434108.xml · nonDerivative · entry 1 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document
May 23, 2019 Filed Aug 6, 2019 20:06 UTC Amendment	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Exercise / conversionRestricted Stock Unit · Derivative	71,575	$9.35	$669,226.25	Disclosure SEC source: 0001628280-19-010125 · wf-form4a_156512200148528.xml · derivative · entry 3 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,575 Underlying: Common Stock · 71,575 shares Expires 2019-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F3 · derivative.exercise_date: Restricted Stock Unit awards granted on July 21,2016, October 19,2017 and July 22, 2018 have accelerated due to resignation on May 23, 2019. Read SEC document
May 23, 2019 Filed Aug 6, 2019 20:06 UTC Amendment	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Tax withholdingCommon Stock	24,750	$9.35	$231,412.50	Disclosure SEC source: 0001628280-19-010125 · wf-form4a_156512200148528.xml · nonDerivative · entry 2 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,015 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · balance_after: Original filing on 5/23/19 and subsequent amendment filing on 5/29/19 inadvertently reported incorrect total number of shares. Read SEC document
May 23, 2019 Filed Aug 6, 2019 20:06 UTC Amendment	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Exercise / conversionCommon Stock	71,575	$9.35	$669,226.25	Disclosure SEC source: 0001628280-19-010125 · wf-form4a_156512200148528.xml · nonDerivative · entry 1 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · balance_after: Original filing on 5/23/19 and subsequent amendment filing on 5/29/19 inadvertently reported incorrect total number of shares. Read SEC document
October 20, 2018 Filed Oct 23, 2018 22:31 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Exercise / conversionRestricted Stock Unit · Derivative	23,703	$0.00	$0.00	Disclosure SEC source: 0001437749-18-018628 · rdgdoc.xml · derivative · entry 3 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,703 shares Expires 2018-10-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on October 20, 2016. F3 · derivative.exercise_date: The restricted stock units vested on October 20, 2018. Read SEC document
October 20, 2018 Filed Oct 23, 2018 22:31 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Tax withholdingCommon Stock	11,751	$14.11	$165,806.61	Disclosure SEC source: 0001437749-18-018628 · rdgdoc.xml · nonDerivative · entry 2 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,190 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document
October 20, 2018 Filed Oct 23, 2018 22:31 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Exercise / conversionCommon Stock	23,703	$14.11	$334,449.33	Disclosure SEC source: 0001437749-18-018628 · rdgdoc.xml · nonDerivative · entry 1 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document
July 25, 2018 Filed Jul 27, 2018 20:22 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative	6,968	$14.35 Strike: $14.35	$99,990.80	Disclosure SEC source: 0001437749-18-013904 · rdgdoc.xml · derivative · entry 4 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 567,500 Underlying: Common Stock · 6,968 shares Expires 2025-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
July 25, 2018 Filed Jul 27, 2018 20:22 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Exercise / conversionNonqualified Stock Option (Right to Buy) · Derivative	35,532	$14.35 Strike: $14.35	$509,884.20	Disclosure SEC source: 0001437749-18-013904 · rdgdoc.xml · derivative · entry 3 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 560,532 Underlying: Common Stock · 35,532 shares Expires 2025-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
July 25, 2018 Filed Jul 27, 2018 20:22 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative	22,794	Not disclosed	Not disclosed	Disclosure SEC source: 0001437749-18-013904 · rdgdoc.xml · derivative · entry 2 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,794 Underlying: Common Stock · 22,794 shares Expires 2021-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The Restricted Stock Units convert into common stock of Landec Corporation on a 1 for 1 basis. F3 · derivative.exercise_date: Restricted Stock Units will be automatically settled in shares of common stock subject to achievement of the performance goals set forth in the Company's LTIP for 2021. Read SEC document
July 25, 2018 Filed Jul 27, 2018 20:22 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative	14,167	Not disclosed	Not disclosed	Disclosure SEC source: 0001437749-18-013904 · rdgdoc.xml · derivative · entry 1 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,167 Underlying: Common Stock · 14,167 shares Expires 2021-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The Restricted Stock Units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.exercise_date: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit. Read SEC document
May 28, 2018 Filed May 30, 2018 19:45 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Exercise / conversionRestricted Stock Unit · Derivative	50,000	$0.00	$0.00	Disclosure SEC source: 0001437749-18-010915 · rdgdoc.xml · derivative · entry 3 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2018-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 28, 2015. F3 · derivative.exercise_date: The restricted stock units vested on May 28, 2018. Read SEC document
May 28, 2018 Filed May 30, 2018 19:45 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Tax withholdingCommon Stock	24,790	$14.05	$348,299.50	Disclosure SEC source: 0001437749-18-010915 · rdgdoc.xml · nonDerivative · entry 2 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,238 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document
May 28, 2018 Filed May 30, 2018 19:45 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Exercise / conversionCommon Stock	50,000	$14.05	$702,500.00	Disclosure SEC source: 0001437749-18-010915 · rdgdoc.xml · nonDerivative · entry 1 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,028 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document
May 23, 2018 Filed May 25, 2018 21:36 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Exercise / conversionRestricted Stock Unit · Derivative	50,000	$0.00	$0.00	Disclosure SEC source: 0001437749-18-010768 · rdgdoc.xml · derivative · entry 3 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 28, 2015. F3 · derivative.exercise_date: The restricted stock units vested on May 23, 2018. Read SEC document
May 23, 2018 Filed May 25, 2018 21:36 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Tax withholdingCommon Stock	24,790	$13.65	$338,383.50	Disclosure SEC source: 0001437749-18-010768 · rdgdoc.xml · nonDerivative · entry 2 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,028 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document
May 23, 2018 Filed May 25, 2018 21:36 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447	Exercise / conversionCommon Stock	50,000	$13.65	$682,500.00	Disclosure SEC source: 0001437749-18-010768 · rdgdoc.xml · nonDerivative · entry 1 Hemmeter Molly · CIK 0001465272 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,818 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.